the study start, we contacted principals of selected kindergartens and primary schools to obtain their permission to join this study. Parents of eligible students in these schools then gave informed written consent for their children to participate in this surveillance. This study did not set any exclusion criterion for subjects in an attempt to recruit a representative study population. Based on local data 
| Subject assessment
Parents completed a questionnaire that recorded subjects' demographics, pre-existing medical illnesses, and influenza vaccination history within 3 years. Our staff verified vaccination history against immunization cards or with responsible doctors. Subjects with the following criteria were considered vaccinated: (i) ≥14 days postvaccination; (ii) received two doses 28 days apart if vaccinated for the first time; or (iii) received at least one dose in a previous influenza season and one dose in the season under study. 5 For surveillance samples, serial flocked nasopharyngeal swabs (FNPSs) were collected every 2 weeks during school visits regardless of whether subjects had respiratory symptoms. Surveillance samples were collected between February and June in 2014 and between January and February in 2015. We started school surveillance within 2 weeks upon announcement of the start of influenza seasons by our CHP. This active influenza surveillance could detect children with asymptomatic or mildly symptomatic infections, which provided an unbiased data on the full spectrum of influenza infections.
Our staff phoned families every 2 weeks to remind subjects about the next surveillance visits and enquire whether they had ILI defined based on modified World Health Organization (WHO) case definition (ie, fever ≥38°C plus two of the followings: cough, sore throat, rhinorrhea, myalgia, headache) 10 and whether they recently received influenza vaccination. Parents were provided our contact phone number and encouraged to inform us as soon as their children developed ILI.
Our team attempted to arrange illness visit for all subjects with ILI during influenza seasons in early 2014 and 2015, and those agreed to attend illness visit returned to our outpatient clinic within 48 hours of ILI onset. During these visits, our nurse collected illness sample and recorded clinical features and concurrent medications.
| NPS collection and processing
Nasopharyngeal sample was collected using flocked swab (Copan Diagnostics, Corona, CA). 11, 12 Swabs taken from both nostrils of a subject were placed in the same specimen bottle containing viral transport medium and transported within 4 hours at room temperature to virology laboratory, where swabs were discarded after vortexing for 20 seconds to release the cells. Viral transport medium was then centrifuged and the pellet resuspended in 1 mL buffered saline and stored at −80°C until analyses. 
| Real-time PCR for influenza virus detection

| Typing of influenza A and B viruses
The Viral load was expressed in the absolute copy numbers of influenza M gene determined from the standard curves generated from a standard plasmid with a known copy number in serial dilutions, which was included in the quantitative PCR simultaneously, as previously described. 13 Real-time PCR was conducted using SYBR Premix EX Taq master mix (Takara Kusatsu, Shiga, Japan), and the results were analyzed using PRISM 7900HT system (Applied Biosystems, Foster City, CA, USA).
| Statistical analysis
Numerical data were expressed either in mean and standard deviation (SD) or median and interquartile range (IQR) as appropriate. The occurrence of laboratory-confirmed influenza or ILI in relation to vaccination was analyzed by logistic regression, adjusting for covariates including seasonality (month of study), subjects' age, sex, body mass index, and comorbid medical conditions. Surveillance data from all influenza seasons were combined during such analyses. Influenza VE was estimated by the "test-negative case-control" design according to published method. 14 As vaccine recipients may have a greater likelihood of seeking health care should they develop infections, this analytical approach adjusts implicitly for this confounding which would otherwise bias VE. All analyses were performed two-tailed using SPSS v.21 (Chicago, IL, USA), with 0.05 being the level of significance. and 36 (9.3%) of 387 school-age children (P<.001). FNPS was not obtained from these subjects because of unavailability of research staff to conduct home visit. In addition, nine illness visits were arranged for five subjects. There was no ILI outbreak in schools or reported transmission of influenza within the same classes and household of influenza-infected children.
| RESULTS
| Study population
| Detection of influenza virus in surveillance samples
Influenza A and B viruses were detected in surveillance samples from 27 to 30 subjects respectively, with median (IQR) viral loads of 918 (99-14 864) copies/μL and 262 (98-324 027) copies/μL, and which were similar between preschool and school-age children (P>.15). in 2015 (P=.025). None of these children were reported by parents to be "sick" at the time of FNPS collection. Besides, our nurses did not notice significant respiratory symptoms in these children at the time of FNPS collection. All illness FNPS samples were negative for both influenza A and B. Table 2 was associated with mild laboratoryconfirmed influenza detected by surveillance (data not shown).
| Relationship between ILI and subjects' demographic and clinical factors
| Effectiveness of influenza vaccination
Sixty-three (18.9%) subjects who received influenza vaccination within 3 years had either IL-I or laboratory-confirmed influenza detected by surveillance, which was significantly lower when compared to 86 (29.7%) children who were not vaccinated (P<.005). Table 3 illustrates the results for influenza VE in our children. Influenza vaccination was protective against ILI (P<.005) but not mild laboratory-confirmed influenza when subjects were vaccinated within 3 years or 12 months.
Influenza vaccine was moderately protective against ILI with VE varied between 42.1% and 51.9% when subjects were vaccinated at different time points before this study. On the other hand, influenza vaccination could not prevent mild laboratory-confirmed influenza that was identified by surveillance. 
| DISCUSSION
Mild laboratory-confirmed influenza in children was common during influenza seasons in 2014 and 2015. Influenza vaccine uptake was 36%-44% among Hong Kong children, and overall influenza VE was moderate (42%-52%) for ILI. Influenza vaccination was effective against ILI but not mild infection identified by our surveillance. More importantly, influenza VE was substantially higher for both ILI and mild laboratory-confirmed influenza in school-age than preschool children.
The prospective cohort design of this study offers an ideal ap- suboptimal vaccine uptake, and poor infection control practices influenced influenza VE. This prospective surveillance study was designed in this direction with biweekly surveillance for influenza A and B viruses by molecular methods. Thus, our results supported seasonal influenza vaccine to be an effective public health measure to prevent ILI in local children. Subgroup analyses revealed that influenza vaccination might be more effective against both ILI and mild laboratory-confirmed influenza in school-age than preschool children (Table 4 ). Another local study reported age-specific VE for influenzarelated hospitalization to be higher in children aged 3-5 years than 6-17 years (91.4% vs 58.1%) in 2015-16. 23 However, both this and our studies were limited by small sample size in each age group which led to wide 95% confidence intervals and significant overlap of the VE estimates. Similar findings were observed in a study of 2368 inpa- was designed to detect both of these A/H3N2 strains. Our government has included children aged 6 months to 5 years as a priority group in the influenza vaccination subsidy scheme. Nonetheless, a small local study found <20% uptake rate in preschool children. 7 In this study, 36%-44% of children received influenza vaccination annually ( Table 1) . Uptake of influenza vaccination was also low among local healthcare workers in the postpandemic era. 29 Breaking barriers to accept influenza vaccination should be a public health priority in fighting against influenza outbreaks. Our findings of moderate overall influenza VE for ILI in children aged 2-12 years together with higher VE against both ILI and mild laboratory-confirmed influenza among the subgroup of school-age children may represent an additional strategy where the Government Vaccination Program can be expanded to cover children up to 12 years old.
We found that influenza vaccination was effective against ILI but not mild infection identified by 2-weekly surveillance during influenza seasons, which was surprising given that all the non-influenza causes of ILI would reduce the observed strength of influenza VE toward the null. One possible explanation relates to study power that we detected many more patients of ILI (n=99) than mild influenza infection (n=57).
On the other hand, influenza-infected children were reported to have increased susceptibility to co-infection by other respiratory pathogens, notably pneumococcus and staphylococcus, which increased the severity of their RTIs. [30] [31] [32] Thus, it is also possible that influenza vaccination prevented ILI by reducing the children with such co-infections.
Vaccinated and unvaccinated patients with influenza infections may exhibit different health care-seeking behavior. This study adopted the test-negative design to define influenza VE as it is less susceptible to bias due to misclassification of infection and to confounding by health care-seeking behavior relative to traditional case-control or cohort studies. 14, 33 Different studies reported that influenza vaccination lowered subject hospitalization rate by 50%-66%. 5, 19, 20 In our research proposal, we targeted to recruit 560 children with evaluable study outcomes which was based on the assumptions of 40% influenza vaccination coverage, Results expressed in number (percentage) for influenza outcomes and mean (95% confidence interval) for VE.
respective influenza attack rates of 13% and 25% among vaccinees and non-vaccinees, and 30% dropout during the surveillance period.
Whereas our cohort of 623 subjects should be sufficient to detect the difference in ILI between vaccinated and non-vaccinated children, this study might not be sufficiently powered to detect the observed difference in laboratory-confirmed influenza among our subjects. Another limitation relates to our inability to detect symptomatic moderate-tosevere laboratory-confirmed influenza. Students absent on the days of school visits were not sampled. Because of frequent school visits, our nurses could not arrange home visits for collecting FNPS from children with ILI for influenza testing. For influenza A(H1N1)pdm09 infection, the revised WHO ILI case definition with fever and cough had low sensitivity (36%) but higher positive predictive value (42%) and positive likelihood ratio (13.3) than the other case definitions. 34 In a Taiwanese study, the presence of fever, cough and sneezing had the best specificity (77%) for laboratory-confirmed influenza. 35 Different ILI case definitions adopted in Europe, USA, and Taiwan had comparable accuracy in sensitivity and specificity, and clinical diagnosis of ILI was useful for providing valuable information for surveillance purpose. This study defined ILI by revised criteria that included other respiratory and constitutional symptoms. It is likely that our patients with ILI had influenza during influenza seasons. Another limitation relates to low participation rates of kindergartens (10/238) and primary schools (5/97), which raised concern if our subjects were recruited by convenience sampling. Nonetheless, we believe our surveillance data were generalizable because these kindergartens and primary schools were identified in sequential random batches from all in our target geographic regions that were registered under the Education Bureau. This study was also limited by the lack of surveillance data for subjects' household and class contacts. Most secondary cases in this surveillance were expected to have minimal influenza symptoms due to low viral load. Unless we collect surveillance samples from subjects' close contacts, we shall miss these secondary cases by only calling them for any ILI symptom.
In conclusion, mild laboratory-confirmed influenza was common among children during influenza seasons in 2014-2015. Moderate overall influenza VE was found for ILI, and subgroup analyses suggested higher VE for both ILI and mild laboratory-confirmed influenza in school-age children. Whether vaccination prevented influenza transmission within families or classes remained unanswered due to lack of reported secondary cases.
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